Supernus Announces Preliminary Fourth Quarter and Full Year 2021 Financial Results

Go back to Supernus Announces Preliminary Fourth Quarter and Full Year 2021 Financial Results
SUPERNUS PHARM (NASDAQ: SUPN) Delayed: 45.25 +0.77 (1.73%)
Previous Close $44.48    52 Week High $26.84 
Open $44.69    52 Week Low $9.51 
Day High $45.38    P/E N/A 
Day Low $44.44    EPS $-2.62 
Volume 27,974